[Bullous photodermatitis caused by the nalidixic acid].
D000328:Adult; D002176:Candida albicans / Q000187:drug effects; D002648:Child; D002908:Chronic Disease; D003937:Diagnosis, Differential; D003875:Drug Eruptions; D005260:Female; D006801:Humans; D008027:Light / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D010787:Photosensitivity Disorders / Q000139:chemically induced* / Q000175:diagnosis; D011164:Porphyrias / Q000175:diagnosis; D012882:Skin Tests; D013057:Spectrum Analysis; D014570:Urologic Diseases / Q000188:drug therapy
D009268:Nalidixic Acid
Bullöse Photodermatitis durch Nalidixinsäure.